Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Spevigo 450 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
spesolimab
Company:  
Boehringer Ingelheim Limited See contact details
ATC code: 
L04AC22
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 15 Jan 2026

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Boehringer Ingelheim Limited
Company image
Address
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone
+44 (0)1344 424 600
WWW
http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line
+44 (0)1344 742579
Medical Information e-mail
[email protected]